Wednesday, April 11, 2012
Generic quetiapine available
BMJ news item. It's lost its patent for the XL (prolonged release) version in the UK, which has been marketed as an add-on in depression (see previous post). At least sense has prevailed about the issue of exclusivity of information about side effects, but maybe I'm keen to thwart AstraZeneca, like the FDA apparently.